1. Define the prevalence and common clinical presentations of neurodevelopmental disorders.
  2. Review the landscape of targeted and precision therapies in development for neurodevelopmental disorders.
  3. Review clinical outcome measures and biomarkers historically used to attain new drug approval through the US Food and Drug Administration.
  4. Discuss future directions in clinical outcome measure and biomarker development in neurodevelopmental disorders.
Session date: 
10/25/2023 - 8:00am to 9:00am CDT
Location: 
UT Southwestern Medical Center-D1.602
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AMA
  • 1.00 Attendance
Please login or create an account to take this course.